Although molecular imaging studies using DAT SPECT and positron emission tomography failed to find significant presynaptic dopaminergic impairment in DRD cases (31), it had similar limitations (i.e., the small sample size and the insufficient control group). This evidence concerns the gene SLC6A3 and dystonia 5.